C
WST icon

Covestor’s West Pharmaceutical WST Stock Holding History

Covestor’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$53K Buy
147
+31
+27% +$9.48K 0.03% 763
2026
Q1 		$29K Sell
116
-87
-43% -$21.6K 0.02% 972
2025
Q4 		$56K Sell
203
-41
-17% -$11.2K 0.03% 870
2025
Q3 		$64K Sell
244
-1
-0.4% -$243 0.04% 794
2025
Q2 		$54K Buy
245
+1
+0.4% +$214 0.03% 869
2025
Q1 		$55K Sell
244
-40
-14% -$11K 0.04% 810
2024
Q4 		$93K Sell
284
-36
-11% -$11.3K 0.06% 577
2024
Q3 		$96K Buy
320
+40
+14% +$12.3K 0.06% 544
2024
Q2 		$92K Buy
280
+231
+471% +$81.6K 0.06% 546
2024
Q1 		$20K Sell
49
-152
-76% -$56.2K 0.01% 1227
2023
Q4 		$71K Sell
201
-17
-8% -$6.02K 0.05% 697
2023
Q3 		$82K Sell
218
-2
-0.9% -$773 0.06% 540
2023
Q2 		$84K Sell
220
-105
-32% -$37.5K 0.06% 541
2023
Q1 		$113K Sell
325
-98
-23% -$28.6K 0.1% 316
2022
Q4 		$100K Buy
423
+42
+11% +$9.95K 0.08% 392
2022
Q3 		$94K Buy
381
+184
+93% +$56.1K 0.08% 390
2022
Q2 		$60K Sell
197
-61
-24% -$19.8K 0.05% 677
2022
Q1 		$106K Buy
258
+107
+71% +$41.9K 0.07% 472
2021
Q4 		$71K Buy
+151
New +$65K 0.1% 336

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Covestor's WST Position: Q2 2026 in Review

Covestor increased its West Pharmaceutical (WST) stake by 27% in Q2 2026, buying an estimated $9.48K and bringing the position to 147 shares worth $53K. The position accounts for 0.03% of the portfolio, ranked #763.

Covestor first reported a position in WST in Q4 2021 and has held it in 19 quarters since. The position peaked at $113K in Q1 2023. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Covestor held 147 shares of West Pharmaceutical worth $53K as of Q2 2026.
  • Covestor bought 31 West Pharmaceutical shares in Q2 2026, an estimated $9.48K.
  • West Pharmaceutical made up 0.03% of Covestor's portfolio in Q2 2026, its #763 holding.
  • Covestor first reported a position in West Pharmaceutical in Q4 2021 and has held it in 19 quarters since.
  • Covestor's West Pharmaceutical position peaked at $113K in Q1 2023.
  • 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.